TY - JOUR
T1 - Reemergence of intravenous drug use as risk factor for Candidemia, Massachusetts, USA
AU - Poowanawittayakom, Nongnooch
AU - Dutta, Anamika
AU - Stock, Shannon
AU - Touray, Sunkaru
AU - Ellison, Richard T.
AU - Levitz, Stuart M.
N1 - Publisher Copyright:
© 2018, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2018/4
Y1 - 2018/4
N2 - The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s-1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis.
AB - The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s-1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis.
UR - http://www.scopus.com/inward/record.url?scp=85044216945&partnerID=8YFLogxK
U2 - 10.3201/eid2404.171807
DO - 10.3201/eid2404.171807
M3 - Article
C2 - 29553923
AN - SCOPUS:85044216945
SN - 1080-6040
VL - 24
SP - 631
EP - 637
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 4
ER -